证券记录 · 已归档季度
VTRS
Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
23被追踪持有人
+2Δ持有人
455.87M持有股份
$4.07B报告持仓市值
+3新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +9.5% ·
股份流向 +2.3% ·
净新建仓位 +8.7%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 10.99M | $194.70M | n/a | −2 |
| Q2 2026 | 148 | -1 | 754.00M | $11.97B | +6 | −8 |
| Q1 2026 | 153 | +6 | 683.49M | $9.23B | +9 | −4 |
| Q4 2025 | 146 | -3 | 743.40M | $9.25B | +1 | −3 |
| Q3 2025 | 22 | -3 | 488.65M | $4.84B | n/a | −4 |
| Q2 2025 | 23 | +2 | 455.87M | $4.07B | +3 | −1 |
| Q1 2025 | 18 | -1 | 210.93M | $1.84B | +1 | −2 |
| Q4 2024 | 19 | -3 | 200.96M | $2.50B | +1 | −4 |
| Q3 2024 | 21 | +3 | 124.36M | $1.44B | +3 | n/a |
| Q2 2024 | 18 | n/a | 121.66M | $1.29B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 145.12M | n/a | $1.30B | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 82.86M | n/a | $739.95M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 3 | T. Rowe Price ✦ | 78.77M | +5.8% | $703.44M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (被动) | 55.29M | -10.0% | $493.72M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 31.23M | +0.2% | $278.33M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Norges Bank ✦ (被动) | 11.54M | -7.5% | $103.09M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Glenview Capital ✦ | 8.25M | -2.9% | $73.65M | 2.1% | ▼ Trim | 5 | SEC ↗ |
| 8 | Millennium Management ✦ | 7.67M | +132.9% | $68.52M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 7.53M | +1034.8% | $67.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 7.43M | +20.8% | $66.34M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | Fidelity (FMR) ✦ | 6.79M | n/a | $60.67M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 12 | D. E. Shaw & Co. ✦ | 4.67M | 新增 | $41.66M | 0.0% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 3.21M | +47.2% | $28.69M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 14 | Gotham Asset Management ✦ | 2.71M | +232.7% | $24.20M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 948.06K | 新增 | $8.47M | 0.0% | New | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 580.46K | +123.7% | $5.18M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 17 | Adage Capital Partners ✦ | 480.74K | -46.3% | $4.29M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 341.42K | -44.1% | $3.05M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 294.08K | -6.4% | $2.63M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Capital World Investors ✦ | 110.68K | 0.0% | $988,355 | 0.0% | Held | 5 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 25.78K | -98.3% | $230,251 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Soros Fund Management ✦ | 12.30K | 新增 | $109,866 | 0.0% | New | 1 | SEC ↗ |
| 23 | Fisher Asset Management ✦ | 10.44K | -24.5% | $93,184 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| D. E. Shaw & Co. | $41.66M | 0.0% |
| Point72 Asset Management | $8.47M | 0.0% |
| Soros Fund Management | $109,866 | 0.0% |
已清仓
| Greenlight Capital (DME… | $52.27M | 曾为 2.6% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,011 持有人, 984.50M 股份, $12.02B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Sep 08
SC 13G/A: FMR LLC
Aug 12
SC 13G/A: DAVIS SELECTED ADVISERS
Aug 06
SC 13G: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据